abs252.txt	background		epstein-barr	virus	(ebv)-positive	gastric	cancers	represent	adistinct	subtype	of	and	account	for	nearly	10%	the	gastriccancer	burden	yet	risk	detection	strategies	this	cancer	are	lacking	methods	we	conducted	a	nested	case-control	study	where	assayed	4	ebv	antigens[viral	capsid	antigen	(vca)	early	(ea)	nuclear	antigen(ebna)	bzlf1-encoded	replication	activator	protein	(zebra)]	in	either	seraor	plasma	from	1447	cases	1797	controls	obtained	sevenprospective	cohorts	representing	individuals	high	cancer-riskcountries	china	japan	korea	results	prevalence	sero-positivity	was	universal	with	exceptionof	one	sero-negative	individual	highest	titers	antigens	vca(or	0	95	95%	ci	78-1	17)	ebna	(or	88	72-1	08)	ea	97	95%ci	79-1	19)	zebra	87	71-1	07)	were	not	associated	withrisk	incident	when	stratified	these	data	by	h	pyloristatus	there	no	change	association	conclusions	multiplex	serology	aforementioned	serum	maynot	be	suitable	biomarker	predicting	east	asianpopulations
